Drug intelligence / Profile preview

ASSAN dolo gel

Development stage
Unknown
Lead developer
Permamed
Modality
Small Molecules
Administration
Topical
01

Overview

ASSAN dolo gel is a topical combination gel developed and marketed by Permamed for the treatment of painful and inflammatory conditions of the musculoskeletal system, including muscles, tendons, ligaments, joints, and the spine, as well as blunt injuries such as bruises, sprains, and strains. It contains three active ingredients: flufenamic acid (a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes), hydroxyethyl salicylate (a salicylate NSAID), and heparin sodium (an anticoagulant that enhances antithrombin-III activity). The gel formulation contains alcohol, providing a soothing cooling effect upon application, and is approved and available over-the-counter in Switzerland.

Brand names
ASSAN doloASSAN dolo gelASSAN emgelASSAN gel
Other names
flufenamic acid + hydroxyethyl salicylate + heparin sodium
02

Targets

ATIII (Antithrombin III)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ASSAN dolo gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASSAN dolo gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call